ESMO 2016: Press brief on results of CABOSUN trial cabozantinib compared to sunitinib in RCC
What is the best sequence of treatment for NSCLC?
S-TRAC Phase III trial of sunitinib as adjuvant therapy in high-risk renal cell cancer patients
Phase III METEOR trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
What impact could biosimilars have?